High circulating SDF-1and MCP-1 levels and genetic variations in CXCL12, CCL2 and CCR5: Prognostic signature of immune recovery status in treated HIV-positive patientsElena Yeregui, Anna Rull, Jenifer Masip et al.|EBioMedicine|2020Cited by 30
Fetuin‐A, inter‐α‐trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomesLaia Reverté, Elena Yeregui, Montserrat Olona et al.|Clinical and Translational Medicine|2022Cited by 16
Adipokines as New Biomarkers of Immune Recovery: Apelin Receptor, RBP4 and ZAG Are Related to CD4+ T-Cell Reconstitution in PLHIV on Suppressive Antiretroviral TherapyElena Yeregui, Anna Rull, Jenifer Masip et al.|International Journal of Molecular Sciences|2022Cited by 10
Omics for searching plasma biomarkers associated with unfavorable COVID-19 progression in hypertensive patientsAlba Sánchez, Anna Rull, Graciano García‐Pardo et al.|Scientific Reports|2025Cited by 2
High Circulating SDF-1 and MCP-1 Levels and Genetic Variations in CXCL12, CCL2 and CCR5: Prognostic Signature of Immune Recovery Status in Treated HIV-Infected PatientsElena Yeregui, Anna Rull, Consuelo Viladés et al.|SSRN Electronic Journal|2020Cited by 0